Nov. 22, 2022—Vanderbilt's Jim Hayman, MS, MBA, has been named to the newly created role of Executive Vice President for the Shared Clinical Services Division.
Nov. 21, 2022—The Meharry-Vanderbilt Alliance recently sponsored the Clifton K. Meador MD Inaugural Lectureship with Christopher Lathan, MD, MS, MPH, chief clinical access and equity officer, Dana-Farber Cancer Institute, serving as keynote speaker.
Nov. 21, 2022—James Ward “Tom” Thomas II, MD, former director of Vanderbilt’s Division of Rheumatology and Immunology, died Nov. 16 following a battle with cancer. He was 74.
Nov. 17, 2022—The Vanderbilt Antimicrobial Stewardship Program provides oversight of antimicrobial therapies for both inpatient and outpatient populations.
Nov. 17, 2022—Vanderbilt researchers have received three grants totaling $13.6 million from the National Institutes of Health to develop molecular “atlases” of the brain, kidney, eye and other tissues.
Nov. 17, 2022—In December Vanderbilt University Medical Center will again update the equation used for estimating kidney function with the goals of improving health equity and better guiding patient care decisions.
Nov. 17, 2022—An in-depth analysis by Vanderbilt investigators of published research studies supports removing race from the calculation of estimated glomerular filtration rate (eGFR) — an assessment of kidney function.
Nov. 17, 2022—Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.